|
Market Closed -
NYSE
23:00:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.640 USD | -3.30% |
|
-1.12% | +46.67% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Other Pharmaceuticals | -3.30% | -1.12% | +46.67% | +51.72% | +76.00% | 213M |  |  | |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
